C4 Therapeutics
CCCC • NASDAQ
C4 Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Andrew J. Hirsch, with a market cap of $276.1M.
Market Cap$276.1M
Employees145.0
CEOAndrew J. Hirsch
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
C4 Therapeutics FAQ
Common questions about C4 Therapeutics
C4 Therapeutics is scheduled to report earnings for Q1 2026 on May 6, 2026. Analysts estimate revenue of $5.5M.
C4 Therapeutics has approximately 145 employees.